Unpublished Ford Study Champagne Joshi
@JoshWalkos
The unpublished Henry Ford study is explosive in its implications. At its
core, the data reveal a stark divide between children who received
vaccines and those who did not. When measured in incidence rates per one
million patient-years, the differences are not subtle. They are dramatic,
and they cut across a wide spectrum of chronic conditions.
The most basic finding is that vaccinated children experienced nearly two
and a half times the overall rate of chronic health conditions compared
to their unvaccinated peers. The number sits at 277.3 cases per million
patient-years among vaccinated children against 111.7 for the
unvaccinated, producing an incidence rate ratio of 2.48 with tight
confidence intervals. That is not a minor signal, it is a flashing red
light.
Asthma stands out as one of the most glaring disparities. The rate was
over four times higher in vaccinated children, 145.6 cases compared to
only 35.6 among the unvaccinated. Atopic diseases such as eczema and
allergies were also elevated, with vaccinated children facing a 2.64-fold
higher risk. Autoimmune conditions were even more striking, with
vaccinated children showing an incidence more than six times greater than
their unvaccinated counterparts.
Neurodevelopmental outcomes were perhaps the most disturbing category.
Disorders in this group were more than six times higher in vaccinated
children. ADHD was present in 262 cases among the vaccinated group, yet
zero among the unvaccinated. Learning disabilities, intellectual
disabilities, tics, and other developmental impairments all followed a
similar pattern. Speech disorders were four times higher among the
vaccinated group, and developmental delays nearly four times higher as
well. Mental health disorders overall were 3.5 times higher. Even seizure
disorders, while less dramatic, still trended upwards with a relative
risk of 1.63.
One of the most telling features of the data is how often the
unvaccinated column registers as zero or near zero. ADHD, learning
disabilities, intellectual disabilities, and tics had no cases recorded
in the unvaccinated population. Critics will argue this reflects
underdiagnosis, since unvaccinated children typically see doctors less
often. But the sheer size of the disparity suggests something more. A
minor diagnostic gap might be plausible, but the gulf revealed in these
numbers is difficult to dismiss as mere chance or office visit frequency.
Taken together, the Henry Ford analysis suggests vaccinated children are
not only more likely to be seen by physicians but also genuinely more
likely to be diagnosed with an array of chronic and developmental
problems. Even if one accepts the possibility of detection bias, the
magnitude of the differences requires serious investigation rather than
casual dismissal. If the signal were a modest ten or twenty percent
increase, one could argue it away. When the risks climb to four, five, or
even six times higher, the argument of bias alone becomes increasingly
fragile.
The larger point is this. Whether or not one accepts every conclusion of
the Henry Ford team, this study provides a powerful signal that chronic
conditions deserve a deeper look in relation to vaccination. Current
post-marketing surveillance systems are primarily designed to catch rare
acute events such as anaphylaxis or febrile seizures. They are not
equipped to track long-term patterns in asthma, autoimmune disease, or
developmental disorders. By design, they will not see what this study has
begun to uncover.
To dismiss this analysis outright because it has not yet passed through
peer review is an act of intellectual laziness. Publication is not the
only measure of value, and in today’s climate researchers face
professional punishment for producing findings that challenge the
dominant narrative.